%0期刊文章%@ 1438- 8871% I JMIR出版物%V 19卡塔尔世界杯8强波胆分析% N 7% P e219% T我的团队的护理研究:飞行员随机对照试验的网络沟通工具协同治疗晚期癌症患者% Voruganti, Teja % Grunfeld,伊娃%吞云吐雾,特雷弗% Kurahashi, Allison M % Lokuge, Bhadra % Krzyzanowska,莫妮卡K % Mamdani,穆罕默德% Moineddin, Rahim %侯赛因,Amna % + Temmy Latner缓和医疗中心西奈山医院,4楼,箱13日60穆雷街,,多伦多,加拿大,1 416 586 4800分机7884,amna.husain@tlcpc.org % K网:互联网%K医患关系%K跨学科沟通%K肿瘤%K成人%K慢性病%K患者护理连续性%K患者护理团队%K沟通%K结果评估(医疗保健)%D 2017 %7 18.07.2017 %9原始论文%J J医学互联网Res %G英语%X背景:管理具有复杂护理需求的患者需要来自多个设置和专业的医疗保健提供者的专业知识。因此，有必要制定跨学科的解决方案，以解决沟通和护理连续性方面的缺陷。我们开发了一个基于web的临床协作工具，称为Loop，它将患者和护理团队聚集在一个虚拟空间中，目的是促进围绕护理管理的沟通。目的:本试点研究的目标是评估将Loop这样的工具集成到当前护理实践中的可行性，并捕获Loop对护理连续性、护理质量、症状窘迫和医疗保健利用的影响的初步措施。方法:我们进行了一项开放标签试点集群随机对照试验，将预后≥3个月的晚期癌症患者(定义为III期或IV期疾病)及其参与的医疗团队和护理人员分配给他们接受Loop干预或常规护理。从患者中每月收集结果数据，持续3个月。试验的可行性通过吸收率、招募率和系统使用率来衡量。Picker护理连续性子量表、姑息治疗结果量表、埃德蒙顿症状评估量表和门诊和家庭护理记录分别是患者自我报告的护理连续性、护理质量、症状痛苦和卫生服务利用的衡量标准。 We conducted a content analysis of messages posted on Loop to understand how the system was used. Results: Nineteen physicians (oncologists or palliative care physicians) were randomized to the intervention or control arms. One hundred twenty-seven of their patients with advanced cancer were approached and 48 patients enrolled. Of 24 patients in the intervention arm, 20 (83.3%) registered onto Loop. In the intervention and control arms, 12 and 11 patients completed three months of follow-up, respectively. A mean of 1.2 (range: 0 to 4) additional healthcare providers with an average total of 3 healthcare providers participated per team. An unadjusted between-arm increase of +11.4 was observed on the Picker scale in favor of the intervention arm. Other measures showed negligible changes. Loop was primarily used for medical care management, symptom reporting, and appointment coordination. Conclusions: The results of this study show that implementation of Loop was feasible. It provides useful information for planning future studies further examining effectiveness and team collaboration. Numerically higher scores were observed for the Loop arm relative to the control arm with respect to continuity of care. Future work is required to understand the incentives and barriers to participation so that the implementation of tools like Loop can be optimized. Trial Registration: ClinicalTrials.gov NCT02372994; https://clinicaltrials.gov/ct2/show/NCT02372994 (Archived by WebCite at http://www.webcitation.org/6r00L4Skb). %M 28720558 %R 10.2196/jmir.7421 %U //www.mybigtv.com/2017/7/e219/ %U https://doi.org/10.2196/jmir.7421 %U http://www.ncbi.nlm.nih.gov/pubmed/28720558